SRx Health Solutions (SRXH)
XASE:SRXH
Want to see SRXH full AI Analyst Report?
SRXH Stock Chart & Stats
$0.24
--
Market closed
$0.24
--
Day’s Range― - ―
52-Week Range$0.08 - $0.78
Previous CloseN/A
VolumeN/A
Average Volume (3M)695.52K
Market Cap
$87.36M
Enterprise Value$5.83M
Total Cash (Recent Filing)$26.07M
Total Debt (Recent Filing)$22.62M
Price to Earnings (P/E)―
Beta0.14
Next Earnings
May 20, 2027EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-213365.32
Shares Outstanding590,254,760
10 Day Avg. Volume504,141
30 Day Avg. Volume695,518
Financial Highlights & Ratios
PEG Ratio>-0.01
Price to Book (P/B)16.44
Price to Sales (P/S)1.02
P/FCF Ratio-0.82
Enterprise Value/Market Cap0.07
Enterprise Value/Revenue-0.19
Enterprise Value/Gross Profit-0.71
Enterprise Value/Ebitda-0.13
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)1.32
Revenue Forecast (FY)$95.00M
Bulls Say, Bears Say
Bulls Say
Specialty Pharmacy & Patient SupportSRx’s core operations center on specialty pharmacy dispensing and patient-support programs, which produce recurring, service-driven revenue and high customer stickiness. These services create durable revenue streams tied to complex therapies and manufacturer contracts, supporting long-term cash inflows if utilization remains stable.
Series B Private Placement CapitalThe March 2026 Series B preferred financing delivered immediate non-dilutive-like capital and extended runway. Structured terms include covenants and registration rights that can improve financing discipline and provide time to execute operational or strategic initiatives without immediate equity dilution risk.
EMJX Merger To Bolster Treasury CapabilitiesPlanned EMJX merger aims to convert SRx’s treasury into a rules-based, multi-asset digital treasury operating system. If executed, this could diversify corporate returns, professionalize cash management, and create a structural enhancement to balance-sheet income generation and liquidity risk management over the medium term.
Bears Say
Elevated Leverage And Thin EquityExtremely high debt relative to equity constrains strategic flexibility and heightens default and refinancing risk. A thin equity base amplifies the impact of operational losses, increases sensitivity to covenant triggers and interest costs, and reduces the firm's capacity to absorb shocks or fund growth organically.
Persistent Cash BurnSustained negative operating and free cash flow indicates reliance on external financing to fund operations. Ongoing cash burn undermines long-term sustainability, increases financing cost and dilution risk, and raises execution risk for strategic initiatives like mergers or capital redeployments if capital access tightens.
Volatile, Currently Weak ProfitabilityHighly variable historical results and a large recent net loss signal unstable margins and weak operating leverage. Volatility in revenue and earnings reduces predictability for partners and payors, complicates long-term planning, and can impair the company’s ability to scale or secure favorable contractual terms.
SRx Health Solutions News
SRXH FAQ
What was SRx Health Solutions’s price range in the past 12 months?
SRx Health Solutions lowest stock price was $0.08 and its highest was $0.78 in the past 12 months.
What is SRx Health Solutions’s market cap?
SRx Health Solutions’s market cap is $87.36M.
When is SRx Health Solutions’s upcoming earnings report date?
SRx Health Solutions’s upcoming earnings report date is May 20, 2027 which is in 339 days.
How were SRx Health Solutions’s earnings last quarter?
SRx Health Solutions released its earnings results on May 14, 2026. The company reported -$0.021 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.021.
Is SRx Health Solutions overvalued?
According to Wall Street analysts SRx Health Solutions’s price is currently Overvalued.
Does SRx Health Solutions pay dividends?
SRx Health Solutions does not currently pay dividends.
What is SRx Health Solutions’s EPS estimate?
SRx Health Solutions’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does SRx Health Solutions have?
SRx Health Solutions has 590,254,760 shares outstanding.
What happened to SRx Health Solutions’s price movement after its last earnings report?
SRx Health Solutions reported an EPS of -$0.021 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -9.42%.
Which hedge fund is a major shareholder of SRx Health Solutions?
Currently, no hedge funds are holding shares in SRXH
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
SRx Health Solutions Stock Smart Score
Company Description
SRx Health Solutions
SRx Health Solutions Inc. functions as a unified Canadian enterprise providing healthcare services, specifically within the specialized medical sector. The company furnishes a complete range of personalized and interconnected specialty healthcare solutions throughout all ten provinces of Canada. Leveraging its deep industry insight, cutting-edge technology, and a patient-first approach, SRx devises strategic programs and services intended to markedly enhance the health and well-being of individuals across the nation.
Technical Analysis
Grifols SA
―
Scilex Holding Company
―
Organon
―
Citius Oncology
―
MIRA Pharmaceuticals, Inc.
―
Ownership Overview
0.28% Insiders
0.02% Mutual Funds
0.04% Other Institutional Investors
99.67% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---